Skip to main content
Fig. 1 | Clinical Hypertension

Fig. 1

From: Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)

Fig. 1

Study disposition. All patients with essential hypertension who had initialed olmesartan/amlodipine/hydrochlorothiazide (OM/AML/HCTZ) at physician’s discretion according to routine clinical considerations were included in this study. The effectiveness analysis set included patients who met enrollment criteria and received follow-up assessment at least once during the observation period after administration of OM/AML/HCTZ at baseline. The safety analysis set included patients who had administered OM/AML/HCTZ at least once during the observation period

Back to article page

Clinical Hypertension

ISSN: 2056-5909

Contact us